Chemical Structure (Phenobarbital 01)
Phenobarbital Sodium Injection
Product Images NDC 42494-441
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Phenobarbital Sodium (NDC 42494-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cameron Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (65 mg/mL Vial Label)
Phenobarbital Sodium Injection, USP is a medication that comes in 25 vials of 1mL, containing 65mg/mL R, and is intended for intramuscular or slow IV use. It should be stored at room temperature (20°-25°C, 68°-77°F), and not be used if discolored or contains a precipitate. The drug is manufactured by Novaplus and is a registered trademark of Wzent B. Expired 2025-04, lot number 23VPSI003, and the SN starts with 654837708946.*
Principal Display Panel (130 mg/mL Vial Label)
PHENOBARBITAL Sodium Injection, USP is an injectable medication with a concentration of 130 mg/mL. It is available in 25 vials, each containing 1 mL. The medication is intended for use via intramuscular or slow intravenous injection. It is important to store the medication at temperatures between 20°C and 25°C (68°F and 77°F). Do not use if the solution is discolored or contains a precipitate. Lot number 23VPSI004 is currently set to expire in 2024.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
